Legend Biotech Corp - ADR

XNAS:LEGN

29.91

+0.02 (+0.07%)

7:26:05 PM EDT: $29.80 -0.11 (-0.37%)

Market Cap (Intraday)	5.56B
Current PE	N/A
Forward PE	1495.5
2yr Forward PE	36.93

See more stats

Estimates Current Quarter

Revenue	$359.68 Million
Adjusted EPS	$0.07

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Legend Biotech Corp - ADR Stock, XNAS:LEGN

2101 Cottontail Lane, Somerset, New Jersey 08873

United States of America

Phone: +1.737.317.5050

Number of Employees: 2609

http://www.legendbiotech.com

Description

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.